NYSE:AMRX
Amneal Pharmaceuticals, Inc.
- Stock
Last Close
6.21
03/05 20:00
Market Cap
1.68B
Beta: 1.32
Volume Today
3.83M
Avg: 1.09M
PE Ratio
151.43
PFCF: 12.36
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | 209.43M - | 169.32M 19.15% | -201.30M 218.89% | -603.57M 199.83% | 68.58M 111.36% | 20.17M 70.59% | -254.79M 1,363.21% | -48.72M 80.88% | |
depreciation and amortization | 33.02M - | 45.94M 39.13% | 137.40M 199.12% | 207.24M 50.82% | 235.39M 13.58% | 233.41M 0.84% | 240.18M 2.90% | 229.40M 4.49% | |
deferred income tax | 121K - | 742K 513.22% | -9.44M 1,372.10% | 371.72M 4,038.09% | 95.64M 74.27% | 83.39M 12.81% | 94.34M - | ||
stock based compensation | 21.40M - | 4.71M 77.98% | 167.60M 3,456.81% | 21.68M 87.06% | 20.75M 4.29% | 28.41M 36.93% | 31.85M 12.09% | 26.82M 15.78% | |
change in working capital | -152.15M - | -1.05M 99.31% | 7.01M 768.89% | -120.22M 1,814.94% | -61.32M 48.99% | -133.59M 117.87% | -59.95M 55.13% | -47.19M 21.28% | |
accounts receivables | -122.48M - | 35.26M 128.78% | 89.08M 152.68% | -132.73M 248.99% | 16.79M 112.65% | -23.62M 240.71% | -79.72M 237.48% | 126.29M 258.42% | |
inventory | -42.59M - | -31.83M 25.27% | -42.88M 34.72% | -20.39M 52.44% | -113.78M 457.95% | -49.02M 56.92% | -102.40M 108.91% | -126.18M 23.23% | |
accounts payables | 6.26M - | 18.11M 188.99% | -55.21M 404.95% | -10.26M 81.42% | 307K 102.99% | -43.93M 14,410.10% | 109.57M 349.40% | -94.45M 186.20% | |
other working capital | 6.65M - | -22.58M 439.48% | 16.01M 170.91% | 43.16M 169.52% | 35.37M 18.05% | -17.02M 148.13% | 12.60M 174.01% | 94.34M 648.72% | |
other non cash items | 3.25M - | 14.52M 346.49% | 148.96M 925.91% | 124.86M 16.18% | 19.96M 84.01% | 10.04M 49.72% | 107.81M 974.25% | 90.92M 15.66% | |
net cash provided by operating activities | 115.06M - | 234.19M 103.53% | 250.23M 6.85% | 1.71M 99.32% | 379.00M 22,128.80% | 241.82M 36.20% | 65.10M 73.08% | 345.58M 430.84% | |
investments in property plant and equipment | -124.61M - | -114.27M 8.29% | -97.09M 15.04% | -97.43M 0.35% | -66.19M 32.07% | -52.64M 20.47% | -90.59M 72.11% | -69.19M 23.63% | |
acquisitions net | 15.72M - | -324.63M 2,165.50% | 34.83M 110.73% | -251.36M 821.59% | -146.54M 41.70% | -84.71M 42.19% | |||
purchases of investments | |||||||||
sales maturities of investments | |||||||||
other investing activites | 25.34M - | 43.02M 69.73% | 5M - | 1M 80% | |||||
net cash used for investing activites | -124.61M - | -98.55M 20.91% | -396.38M 302.19% | -19.58M 95.06% | -317.55M 1,521.79% | -194.18M 38.85% | -174.31M 10.23% | -69.19M 60.31% | |
debt repayment | -36.40M - | -13.90M 61.81% | -784.34M 5,543.11% | -29.27M 96.27% | -37.01M 26.45% | -79.18M 113.93% | -123.27M 55.69% | -414.08M 235.91% | |
common stock issued | 662K - | ||||||||
common stock repurchased | -926K - | -863K 6.80% | -2.66M 208.69% | -3.57M 34.05% | |||||
dividends paid | -200.62M - | -375.26M 87.06% | -183.00M 51.23% | -3.57M - | |||||
other financing activites | 217.52M - | 294.15M 35.23% | 1.26B 326.66% | -15.64M 101.25% | 169.68M 1,185.13% | -56.28M 133.17% | 23.13M 141.10% | 201.51M 771.12% | |
net cash used provided by financing activities | -19.50M - | -95.02M 387.38% | 287.68M 402.77% | -45.83M 115.93% | 131.81M 387.58% | -138.12M 204.79% | -106.62M 22.81% | -212.57M 99.37% | |
effect of forex changes on cash | 1.48M - | -242K 116.34% | -670K 176.86% | -2.25M 235.67% | 1.04M 146.11% | 102K 90.16% | -5.68M 5,671.57% | 65K 101.14% | |
net change in cash | -27.56M - | 40.38M 246.50% | 140.86M 248.86% | -65.96M 146.83% | 194.30M 394.58% | -90.38M 146.52% | -221.51M 145.08% | 63.88M 128.84% | |
cash at beginning of period | 65.11M - | 37.55M 42.33% | 77.92M 107.54% | 218.78M 180.77% | 152.82M 30.15% | 347.12M 127.14% | 256.74M 26.04% | 35.23M 86.28% | |
cash at end of period | 37.55M - | 77.92M 107.54% | 218.78M 180.77% | 152.82M 30.15% | 347.12M 127.14% | 256.74M 26.04% | 35.23M 86.28% | 99.11M 181.34% | |
operating cash flow | 115.06M - | 234.19M 103.53% | 250.23M 6.85% | 1.71M 99.32% | 379.00M 22,128.80% | 241.82M 36.20% | 65.10M 73.08% | 345.58M 430.84% | |
capital expenditure | -124.61M - | -114.27M 8.29% | -97.09M 15.04% | -97.43M 0.35% | -66.19M 32.07% | -52.64M 20.47% | -90.59M 72.11% | -69.19M 23.63% | |
free cash flow | -9.55M - | 119.92M 1,356.19% | 153.14M 27.71% | -95.73M 162.51% | 312.81M 426.78% | 189.18M 39.52% | -25.50M 113.48% | 276.39M 1,184.09% |
All numbers in USD (except ratios and percentages)